Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Feb 28, 2023
Q2 FY2023
As of Nov 30, 2022
Q1 FY2023
As of Aug 31, 2022
Q4 FY2022
As of May 31, 2022
Q3 FY2022
As of Feb 28, 2022
Q2 FY2022
As of Nov 30, 2021
Q1 FY2022
As of Aug 31, 2021
Q4 FY2021
As of May 31, 2021
Q3 FY2021
As of Feb 28, 2021
Q2 FY2021
As of Nov 30, 2020
Q1 FY2021
As of Aug 31, 2020
Q4 FY2020
As of May 31, 2020
Q3 FY2020
As of Feb 29, 2020
Q2 FY2020
As of Nov 30, 2019
ASSETS
CURRENT ASSETS:
Accounts receivable
Vendor deposits
Cash and cash equivalents
Inventory
Deposits
Prepaids and other current assets
Total current assets
Investments in equity securities, at cost
Equipment, net
Right to use asset
Cannabis licenses
Finite-lived intangible assets, net
Indefinite-lived intangible assets, net
Total non-current assets
Total Assets
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Accounts payable
Payable for discontinued operations (Note 3)
Accounts payable and accrued liabilities
Customer deposits
Payable to related parties
Accounts payable and accrued expenses
Accounts payable to related parties
Advances from related parties
Accrued interest payable
Accrued rent payable - related party
Lease liability - current portion
Put option liability
Put option liablility
Satellite note payable, net of discount
Diagonal convertible note payable
Convertible note payable - related party
 Notes payable, net of discount
Other current liabilities
Total current liabilities
LONG-TERM LIABILITIES:
Payable to related parties for services
 Total long-term liabilities 
 Accounts payable to related parties - long-term
 Lease liability - long-term
 Advance from non-related party
Accounts payable - long-term
Common stock payable
Payables to related parties - long-term
Accounts payable - long term
Lease liability - long term
Satellite note payable, net of discount – long term
Satellite note payable, note of discount – long term
Satellite note payable, net of discount - long term
Advances from related parties
Total long-term liabilities
Total Liabilities
Common stock, $0.0001 par value, 100,000,000 shares authorized; 44,854,737 and 33,574,436 shares issued and outstanding, respectively
Common stock subject to cancellation on dicontinued operations (1,300,000 shares) (Note 3)
Additional paid-in capital
Accumulated deficit
Total stockholders' equity (deficit)
Total Liabilities and Stockholders' Equity (Deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support